Paul Rubin

2.9k citations

39 papers · 1.8k indexed · h-index 18

Impact in

Physiology top 2%
- Asthma and respiratory diseases
Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization

Papers in

Dermatology 8
- Cutaneous lymphoproliferative disorders research 5
Pharmacology 8
- Inflammatory mediators and NSAID effects 5

Co-authors: Jeffrey M. Drazen Elliot Israel Mitchell Rosenberg Graham W. Taylor Richard I. Sperling Craig M. Lilly Andrew R. Fischer J. Cohn
Journals: International Journal of Radiation Oncology*Biology*Physics (2 papers)Journal of Allergy and Clinical Immunology (2 papers)Diabetes (2 papers)Journal of Investigative Dermatology (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)
Partner nations: United States Canada Denmark

In The Last Decade

Paul Rubin

38 papers receiving 1.8k citations

Peers

Countries citing papers authored by Paul Rubin

Since Specialization

Citations

This map shows the geographic impact of Paul Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Rubin more than expected).

Fields of papers citing papers by Paul Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Rubin. The network helps show where Paul Rubin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Rubin Line = papers co-authored together Paul Rubin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	866-P: The Apelin Receptor Agonist Azelaprag Shows Cardioprotective Effects as Monotherapy and Enhanced Benefits with Semaglutide in a Diet-Induced Obesity Model of Heart Failure with Preserved Ejection Fraction Diabetes ·詹平, Robert Commanday, Yan Wang, Dai XinJian, A Massoutier, Julia Schenkenberger, Juanita Harrisa, Dan Yang, Alessandra Mileni Versuti Ritter, Cai Xu-x, Changyuan Liang, Justin Rebo, Rusty L. Montgomery, Eric Morgen, Kristen Fortney, Paul Rubin	2025	0
2	Next Generation miR-29 Mimics as a Therapy for Pulmonary Fibrosis Rusty L. Montgomery, Subhadeep Roy, Kevin M. Rigby, Aimee L. Jackson, Paul Rubin	2019	1
3	A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin Journal of Investigative Dermatology ·Corrie L. Gallant‐Behm, Joseph Piper, Joshua M. Lynch, Anita G. Seto, Seok Jong Hong, Thomas A. Mustoe, Catherine Maari, Linda Pestano, O. M. Holich, Aimee L. Jackson, Paul Rubin, William S. Marshall	2018	205
4	Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers The Journal of Clinical Endocrinology & Metabolism ·Kirk W. Johnson, Brenda Jhuthi, Allan Gordon, 郭开鹤, P. van Doornick, 安鲁彪, Ira D. Goldfine, Paul Rubin	2017	12
5	LB948 Pharmacodynamic activity of a microRNA-29b mimic (MRG-201) in human skin incisions Journal of Investigative Dermatology ·Corrie L. Gallant‐Behm, Catherine Maari, Aimee L. Jackson, Anita G. Seto, Joshua M. Lynch, Judy Ruckman, Paula Aeennee Yañez González, Linda Pestano, Brent Dickinson, O. M. Holich, Manfred Huwer, David M. Rodman, Gary G. Gordon, Paul Rubin, William S. Marshall	2017	2
6	PH 1 TRIAL EVALUATING MRG‐106, A MICRORNA‐155 INHIBITOR, ADMINISTERED BY INTRATUMORAL, SUBCUTANEOUS, OR INTRAVENOUS DELIVERY IN CUTANEOUS T‐CELL LYMPHOMA (CTCL) PATIENTS Hematological Oncology ·Christiane Querfeld, Francine M. Foss, Pierluigi Porcu, Y.H. Kim, Theresa Pacheco, Bradley M. Haverkos, Ahmad Halwani, Jennifer DeSimone, Basem M. William, Lauren Pinter‐Brown, Anita G. Seto, Judy Ruckman, Paula Aeennee Yañez González, Aimee L. Jackson, Brent Dickinson, Manfred Huwer, David M. Rodman, Paul Rubin, William S. Marshall	2017	2
7	Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients Blood ·Christiane Querfeld, Francine M. Foss, Lauren Pinter‐Brown, Pierluigi Porcu, Basem M. William, Theresa Pacheco, Bradley M. Haverkos, Youn H. Kim, Joan Guitart, Ahmad Halwani, Jennifer DeSimone, Anita G. Seto, Linda Pestano, Aimee L. Jackson, Paul J. Williams, Brent Dickinson, Judy Ruckman, Gilad S. Gordon, Paul Rubin, K. M. Ahmad	2017	25
8	A Novel Allosteric Insulin Receptor–Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys Journal of Pharmacology and Experimental Therapeutics ·P. van Doornick, Jingsong Zhao, 陆嘉惠濮晓珍卓露, J. C. Pionnat, V. Tvaskis, Ago Ahene, Paul Rubin, K Johnson	2015	11
9	XOMA 089, a Novel Anti-TGF-beta Monoclonal Antibody, Inhibits Experimental Proliferative Vitreoretinopathy in Rabbits Investigative Ophthalmology & Visual Science ·Amer M. Mirza, Jingsong Zhao, Nerissa Mendoza, O Sánchez, Xinying Li, J. C. Pionnat, V. Tvaskis, Paul Rubin	2014	1
10	Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids Prostaglandins & Other Lipid Mediators ·Paul Rubin, Karl W. Mollison	2007	56
11	Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma☆☆☆★★★ Journal of Allergy and Clinical Immunology ·Harold S. Nelson, George Bensch, Warren Pleskow, Rachael L. DiSantostefano, Anne Finch, David S. Reasner, Thomas E. Rollins, Paul Rubin	1998	153
12	Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma Journal of Allergy and Clinical Immunology ·Andrew R. Fischer, Mitchell Rosenberg, Craig M. Lilly, E Grassl, Paul Rubin, J. Cohn, Martha V. White, Yasushi Igarashi, Michael Kaliner, Jeffrey M. Drazen, Elliot Israel	1994	135
13	The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin American Review of Respiratory Disease ·Elliot Israel, Andrew R. Fischer, Mitchell Rosenberg, Craig M. Lilly, E Grassl, Jerry Shapiro, J. Cohn, Paul Rubin, Jeffrey M. Drazen	1993	291
14	The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor International Journal of Immunopharmacology ·Randy L. Bell, Patrick Young, Daniel H. Albert, Carmine Lanni, James B. Summers, Dee W. Brooks, Paul Rubin, P Antoine	1992	99
15	Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivo Inflammation Research ·Pierré Sirois, P Borgeat, Francesca Giuliani, Louise M. Dubé, Paul Rubin, J. W. Kesterson	1991	30
16	Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax ·K.P. Hui, Ian Taylor, Graham W. Taylor, Paul Rubin, J. W. Kesterson, N. Barnes, Peter J. Barnes	1991	136
17	The identification of new early molecular mechanisms in the pathogenesis of radiation-induced pulmonary fibrosis International Journal of Radiation OncologyBiologyPhysics ·Paul Rubin, Jacob N. Finkelstein, Stuart A.C. McDonald, Stuart Horowitz, Robert A. Sinkin	1991	8
18	The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry Air New England Journal of Medicine ·Elliot Israel, 實鎌田, Mitchell Rosenberg, Richard I. Sperling, Graham W. Taylor, Paul Rubin, Jeffrey M. Drazen	1990	304
19	Comparison of Repeat Doses of Intramuscular Ketorolac Tromethamine and Morphine Sulfate for Analgesia after Major Surgery Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Colin Brown, Kaung Suk Jo, Martin S. Mok, Luo Chi-Hsun, Paul Rubin, Wayne H. Schwesinger	1990	58
20	[On 4 cases of severe hypoglycemia (one of which with fatal evolution) after treatment with glibenclamide]. PubMed ·Maleeha Ijaz, Paul Rubin, Himatul Khoeroh, Stefania Di Leo	1971	2

About Paul Rubin

Paul Rubin is a scholar working on Dermatology, Pharmacology, Endocrinology, Diabetes and Metabolism, Physiology and Pathology and Forensic Medicine, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (9 papers), Cutaneous lymphoproliferative disorders research (5 papers), Inflammatory mediators and NSAID effects (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Diabetes Management and Research (3 papers), CAR-T cell therapy research (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Physiology (969 citations), Immunology and Allergy (215 citations), Pharmacology (387 citations), Pulmonary and Respiratory Medicine (622 citations) and Cancer Research (154 citations). Paul Rubin has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include Jeffrey M. Drazen, Elliot Israel, Mitchell Rosenberg, Graham W. Taylor, Richard I. Sperling, Craig M. Lilly, Andrew R. Fischer, J. Cohn, Jerry Shapiro and Karl W. Mollison. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Allergy and Clinical Immunology, Diabetes, Journal of Investigative Dermatology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact